Goldman Sachs’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Buy |
1,142,799
+456,032
| +66% | +$5.13M | ﹤0.01% | 2087 |
|
|
2025
Q1 | $3.91M | Buy |
686,767
+139,126
| +25% | +$793K | ﹤0.01% | 2921 |
|
|
2024
Q4 | $5.38M | Buy |
547,641
+180,601
| +49% | +$1.77M | ﹤0.01% | 2806 |
|
|
2024
Q3 | $2.99M | Buy |
367,040
+227,522
| +163% | +$1.85M | ﹤0.01% | 3090 |
|
|
2024
Q2 | $1.87M | Buy |
139,518
+85,410
| +158% | +$1.14M | ﹤0.01% | 3229 |
|
|
2024
Q1 | $2.51M | Buy |
54,108
+36,506
| +207% | +$1.69M | ﹤0.01% | 3057 |
|
|
2023
Q4 | $1.19M | Sell |
17,602
-7,535
| -30% | -$509K | ﹤0.01% | 3525 |
|
|
2023
Q3 | $1.82M | Buy |
25,137
+14,057
| +127% | +$1.02M | ﹤0.01% | 3148 |
|
|
2023
Q2 | $824K | Buy |
11,080
+5,357
| +94% | +$399K | ﹤0.01% | 3731 |
|
|
2023
Q1 | $304K | Sell |
5,723
-31,594
| -85% | -$1.68M | ﹤0.01% | 4329 |
|
|
2022
Q4 | $2.52M | Buy |
37,317
+10,115
| +37% | +$684K | ﹤0.01% | 3116 |
|
|
2022
Q3 | $3.4M | Sell |
27,202
-78,904
| -74% | -$9.85M | ﹤0.01% | 2955 |
|
|
2022
Q2 | $10.1M | Buy |
106,106
+98,109
| +1,227% | +$9.34M | ﹤0.01% | 2129 |
|
|
2022
Q1 | $1.29M | Buy |
+7,997
| New | +$1.29M | ﹤0.01% | 3927 |
|